Peter Powchik

Keine laufenden Positionen mehr

Vermögen: 27 329 $ am 30.04.2024

67 Jahre

95 Beziehungen

Health Technology

Distribution Services

Consumer Services

Karriereverlauf von Peter Powchik

Ehemalige bekannte Positionen von Peter Powchik

Unternehmen	Position	Beginn	Ende
VAXXINITY, INC.	Direktor/Vorstandsmitglied	31.03.2022	31.03.2024
	Technik-/Wissenschafts-/F&E-Leiter	01.10.2023	31.03.2024
	Corporate Officer/Principal	01.10.2023	31.03.2024
REGENERON PHARMACEUTICALS, INC.	Corporate Officer/Principal	01.10.2006	01.01.2018
Chugai Pharma USA LLC Chugai Pharma USA LLC Medical DistributorsDistribution Services Part of Roche Holding AG, Chugai Pharma USA LLC is a private company that develops safe and effective drugs. The company is based in Bedminster, NJ.	Technik-/Wissenschafts-/F&E-Leiter	01.05.2005	01.10.2006
Novartis Pharmaceuticals Corp. Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Corp. develops, manufactures, and markets prescription drugs. It manufactures and markets prescription drugs used to treat a number of diseases and conditions including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease, and respiratory. The company was founded in 1996 and is headquartered in East Hanover, NJ.	Technik-/Wissenschafts-/F&E-Leiter	01.04.2001	01.05.2005
PFIZER, INC.	Corporate Officer/Principal	01.04.2001	01.04.2001
Chugai Pharma USA, Inc.	Technik-/Wissenschafts-/F&E-Leiter	-	-
Sumitomo Pharma America, Inc. Sumitomo Pharma America, Inc. Pharmaceuticals: MajorHealth Technology Sumitomo Pharma America, Inc. operates as a biopharmaceutical company that develops pharmaceutical products. Its products include Aptiom (eslicarbazepine acetate) tablets, Latuda (lurasidone HCl) tablets, Lunesta (eszopiclone) tablets, Xopenex (levalbuterol HCl) Inhalation Solution, Xopenex HFA (levalbuterol tartrate) Inhalation Aerosol, Brovana (arformoterol tartrate) Inhalation Solution, Omnaris (ciclesonide) Nasal Spray, Alvesco (ciclesonide) Inhalation Aerosol, and Zetonna (ciclesonide) Nasal Aerosol. The company was founded in 2010 and is headquartered in Marlborough, MA.	Technik-/Wissenschafts-/F&E-Leiter	-	-

Ausbildung von Peter Powchik

New York University School of Medicine

Doctorate Degree

Statistik

International

Vereinigte Staaten

Operativ

Chief Tech/Sci/R&D Officer	5
Corporate Officer/Principal	3
Doctorate Degree	1

Sektoral

Health Technology	6
Distribution Services	2
Consumer Services	2

Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Unternehmensverbindungen

Börsennotierte Unternehmen	3
REGENERON PHARMACEUTICALS, INC.	Health Technology
PFIZER, INC.	Health Technology
VAXXINITY, INC.	Health Technology

Private Unternehmen	4
Chugai Pharma USA LLC Chugai Pharma USA LLC Medical DistributorsDistribution Services Part of Roche Holding AG, Chugai Pharma USA LLC is a private company that develops safe and effective drugs. The company is based in Bedminster, NJ.	Distribution Services
Novartis Pharmaceuticals Corp. Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Corp. develops, manufactures, and markets prescription drugs. It manufactures and markets prescription drugs used to treat a number of diseases and conditions including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease, and respiratory. The company was founded in 1996 and is headquartered in East Hanover, NJ.	Health Technology
Sumitomo Pharma America, Inc. Sumitomo Pharma America, Inc. Pharmaceuticals: MajorHealth Technology Sumitomo Pharma America, Inc. operates as a biopharmaceutical company that develops pharmaceutical products. Its products include Aptiom (eslicarbazepine acetate) tablets, Latuda (lurasidone HCl) tablets, Lunesta (eszopiclone) tablets, Xopenex (levalbuterol HCl) Inhalation Solution, Xopenex HFA (levalbuterol tartrate) Inhalation Aerosol, Brovana (arformoterol tartrate) Inhalation Solution, Omnaris (ciclesonide) Nasal Spray, Alvesco (ciclesonide) Inhalation Aerosol, and Zetonna (ciclesonide) Nasal Aerosol. The company was founded in 2010 and is headquartered in Marlborough, MA.	Health Technology
Chugai Pharma USA, Inc.

Sehen Sie sich die Unternehmensverbindungen an